L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)
Christopher Sweeney,Wanling Xie,Meredith M. Regan,Mari Nakabayashi,Marc Buyse,Noel W. Clarke,Laurence Collette,James J. Dignam,Karim Fizazi,Muriel Habibian,Susan Halabi,Philip W. Kantoff,Wendy R. Parulekar,Howard M. Sandler,Oliver Sartor,Howard R. Soule,Matthew R. Sydes,Bertrand F. Tombal,Scott Williams +18 more
TL;DR: The Intermediate Clinical Endpoints in CaP (ICECaP) Working Group is conducting an indi... as mentioned in this paper, where advances in the treatment of localized CaP have led to decreased recurrences and improved OS.
Journal ArticleDOI
Comment on the “TrialsTracker: Automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions”
TL;DR: The purpose of this correspondence is to discuss the TrialsTracker, presented by Powell-Smith and Goldacre in their article ‘TrialsTracker: Automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions’ (2016) as a tool to discover publication bias inclinical trial results.
Journal ArticleDOI
EORTC prostate cancer trials: what have we learnt?
TL;DR: It has been learnt that the primary tumour should not be used for response assessment in advanced disease but that Quality of life (QoL) assessment consistently applied may be and that anti-androgen monotherapy approach in patients with M+ disease with good prognostic factors has been shown to be feasible.
Journal ArticleDOI
Prostate cancer: to screen or not to screen?
Urs E. Studer,Laurence Collette +1 more
TL;DR: Two European authors speculate as to the reasons underlying this contradiction in interim analyses of the long-awaited ERSPC and PLCO trial data, while highlighting clinically relevant points that are supported by both studies.
Journal ArticleDOI
Impact of acute kidney injury on anticancer treatment dosage and long-term outcomes: a pooled analysis of European Organisation for Research and Treatment of Cancer trials.
Julien Péron,Julien Péron,Anouk Neven,Laurence Collette,Vincent Launay-Vacher,Ben Sprangers,Sandrine Marreaud +6 more
TL;DR: Close monitoring of the kidney function during the first months of treatment should be included in clinical trial protocols and probably also in daily practice to enable early AKI diagnosis and management.